TNF-α involvement in the pathogenesis of IBD is reflected in local cytokine expression in the gut tissue, as well as the therapeutic efficacy of anti-TNF agents for both Crohn's disease (CD) and ulcerative colitis (UC) [2]. This evidence concerns the gene TNF and Crohn disease.